Long-term treatment with oral enoximone for chronic congestive heart failure: The European experience
- 14 August 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (5) , 85-90
- https://doi.org/10.1016/0002-9149(87)90533-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failureThe American Journal of Cardiology, 1986
- Epidemiology of congestive heart failureThe American Journal of Cardiology, 1985
- Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1984
- Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticismJournal of the American College of Cardiology, 1983
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983
- Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.Circulation, 1982
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- Long-term amrinone therapy in patients with severe heart failureThe American Journal of Medicine, 1982
- The natural history of idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1981